Leachianone A

Leachianone A

SCHEMBL904467

C=C(C)C(CC=C(C)C)Cc1c(O)cc(O)c2c1OC(c1ccc(O)cc1OC)CC2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 9/20 1.00
▸ ESR1 P03372 4/20 0.83
▸ SLC5A1 P13866 2/20 0.83
▸ SLC5A2 P31639 2/20 0.83
▸ PTGS1 P23219 1/20 0.83
▸ SOAT1 P35610 1/20 0.83
▸ BCHE P06276 1/20 0.83
▸ ACHE P22303 1/20 0.83
▸ ABCG2 Q9UNQ0 4/20 0.82
▸ CACNA1G O43497 2/20 0.82
▸ CACNA1H O95180 2/20 0.82
▸ MAOA P21397 2/20 0.53
▸ MAOB P27338 1/20 0.53
▸ AKR1B10 O60218 2/20 0.53
▸ AKR1B1 P15121 2/20 0.53
▸ PDPK1 O15530 1/20 0.53
▸ PRKCA P17252 1/20 0.53
▸ PRKCQ Q04759 1/20 0.53
▸ ESR2 Q92731 2/20 0.51
▸ PDE5A O76074 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leachianone A SCHEMBL29415618 1.00 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
Leachianone A SCHEMBL27013422 1.00 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
Leachianone A SCHEMBL30766171 1.00 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
SCHEMBL15386077 0.96 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
SCHEMBL27013509 0.96 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
SCHEMBL31237251 0.96 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
SCHEMBL15452193 0.96 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
SCHEMBL10307770 0.93 BACE1 (0.86) BACE1ESR1SLC5A1SLC5A2PTGS1
Kurarinone SCHEMBL904627 0.91 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1
Kurarinone SCHEMBL10307523 0.91 BACE1 (1.00) BACE1ESR1SLC5A1SLC5A2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9326968-B2 Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-05-03 — — US disclosed
US-9326968-B2 Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-05-03 — — US disclosed
US-9326968-B2 Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2016-05-03 — — US disclosed
US-20130303474-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING COMPOUNDS REPRESENTED BY CHEMICAL FORMULAS 1-8 OR SOPHORA FLAVESCENS EXTRACT AS ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) 2013-11-14 — — US disclosed
US-20130303474-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING COMPOUNDS REPRESENTED BY CHEMICAL FORMULAS 1-8 OR SOPHORA FLAVESCENS EXTRACT AS ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) 2013-11-14 — — US disclosed
US-20130303474-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING COMPOUNDS REPRESENTED BY CHEMICAL FORMULAS 1-8 OR SOPHORA FLAVESCENS EXTRACT AS ACTIVE INGREDIENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) 2013-11-14 — — US disclosed
WO-2012043949-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING COMPOUNDS REPRESENTED BY CHEMICAL FORMULAS 1-8 OR SOPHORA FLAVESCENS EXTRACT AS ACTIVE INGREDIENT 한국생명공학연구원 (KR) 2012-04-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303474-A1 COMPOSITION FOR ENHANCING IMMUNITY CONTAINING COMPOUNDS REPRESENTED BY CHEMICAL FORMULAS 1-8 OR SOPHORA FLAVESCENS EXTRACT AS ACTIVE INGREDIENT IRF3, IFNG, IRF2BP2 BACE1 242/4885ESR1 2901/4885SLC5A1 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback